F.A.Q.’s

Check back often, this page is constantly under construction as we work to bring you the newest and most relevant answers!

Who should be tested for Neurocognitive impairment?

Patient groups who are very likely to be tested up to four times a year are:

  • Geriatric
  • Stroke
  • Traumatic Brain Injury
  • MCI/Dementia
  • AD/HD – adult and adolescent

  • Overweight
  • Known or suspected substance abuse (including smoking cessation)
  • Diabetes
  • Mood Disorders
  • Other behavioral issues

There are no restrictions on demographic or psychographic segments

  • Age: 7 – 99
  • Male/Female
  • Household income is irrelevant
  • Grade school to post graduate education

  • All occupations
  • Any lifestyle, religion, psychographics, hobbies
  • Any business type or size, employees or employers
  • Available in over 60 languages

What types of practice see a higher incident of Mild Cognitive Impairment?

Primary Care Physicians, including:

  • General Practitioners
  • Family Practitioners
  • Adult Medical Practitioners

Also:

  • Pain Management
  • Orthopedics
  • Sports Medicine
  • Neurologists
  • Internal Medicine
  • Endocrinologists
  • Podiatrists

Why Measure Neurocognition?

Important Clinical Biomarker that is not easily assessed

  • “Neurocognition” refers to the higher brain functions: learning, remembering, concentrating, solving problems, and making decisions. Neurocognitive processes are active in virtually all of our day‐to‐day activities.
  • Neurocognition begins with our genetic uniqueness and the maternal health given early in life. Environmental factors (nutrition, diet, exercise and sleep) begin contributing to our neurocognitive or brain health… the nurturing, training and support we receive early in life helps set a neurocognitive and behavioral development trajectory that can impact us for the rest of our lives.
  • Our maximum neurocognitive potential is generally realized in the young adult stage of our lifespan… however, environmental factors continue to interact with our genes creating a trajectory for brain health that contributes to our overall quality‐of‐life throughout our lifespan.
  • Collectively our brain and behavioral health status is vitally important for the healthy functioning of families, communities and society. Together, they fundamentally can affect our individual success and happiness and collectively our general prosperity.
  • The complexity of an individual’s genetic makeup and varied environmental experiences makes assessing and optimizing neurocognitive health a clinical challenge.
  • Neurocognitive and behavioral assessments can help clinicians evaluate and describe the neurocognitive health or higher functions of our brains and our mental and emotional well-being through our lifespan.